Full-Time

Retail Inventory Associate

Posted on 10/1/2025

TerrAscend

TerrAscend

201-500 employees

Global cannabis cultivation, processing, and retail

Compensation Overview

$16/hr

South Orange, NJ, USA

In Person

Category
Administrative & Executive Assistance (1)
Required Skills
Inventory Management
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Experience with audits and month ending reporting processes.
  • Strong inventory track record.
  • Understanding in Metrc and Sweed platforms is a plus.
  • Working knowledge of Excel, inventory management software and tools, and use of other software systems used for analytics.
  • Strong organizational skills.
  • Professional written and verbal communication with multiple levels and departments.
  • Knowledge of office management systems and procedures.
  • Good interpersonal skills and proven ability to positively influence people; must be capable of effectively interacting at all levels in the organization.
  • Detail-oriented with an eye on process optimization.
  • Ability to work in a fast-paced environment, to manage high stress situations, and to be flexible and adaptable when a situation requires it.
  • Accurate, self-starter, troubleshooter, with an emphasis on work product ownership, with the ability to prioritize and complete tasks with competing deadlines.
  • Analytical and detail oriented. Preferably a proven record of working effectively with patients and a strong understanding of 'real-store-time' efficiencies.
  • Must be flexible safeguarding operating dispensary hours, which includes evenings, weekends, and holidays.
  • Available for month-end inventory audits which take place after business hours (3x a month until 1-2am).
Responsibilities
  • Assist with inventory team to receive incoming inventory and prepare it for placement on the menu.
  • Work closely with Retail Operations Supervisor and Inventory Specialist to plan and execute inventory counts in the dispensary.
  • Examine the levels of products, systems vs. physical to determine shortages, to find and report root causes for process improvement.
  • Assist with formal Systems vs. Physical Count Reports on inventory and provide to Management monthly.
  • Monitor inventory receiving process for accuracy, completion, proper documentation, and timeliness.
  • Participate (hands-on) in EOM (End-of-month) inventory and cycle counts to set work standards, reconcile, validate, and execute on count results.
  • Ensure that inventory control processes follow state CRC regulations.
  • This position will be involved in monthly inventory audits and counts that involve counting inventory after the store closes or before the store opens.
Desired Qualifications
  • 1+ years industry experience preferred.
  • Inventory experience preferred.

TerrAscend operates globally in the cannabis sector, covering cultivation, processing, manufacturing, and retail. It grows cannabis plants, turns them into products such as dried flowers, oils, edibles, and other infused goods, and sells these through its own retail brands and distribution channels. The company also provides ancillary services to support the cannabis industry. What makes TerrAscend different is its integrated, multi-country footprint and strategy of strategic acquisitions (including Arise Bioscience, The Apothecarium, State Flower, and Ilera Healthcare) to expand its brands and market presence, while maintaining strong standards for quality and regulatory compliance grounded in scientific research. Its goal is to continue growing its market position by expanding its product range, geographic reach, and capabilities through innovation, rigorous quality control, and acquisitions, serving medical patients, recreational users, and other cannabis industry businesses.

Company Size

201-500

Company Stage

IPO

Headquarters

Ontario, California

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Pennsylvania adult-use legalization creates $1.5B market for existing cultivation and retail.
  • DEA Schedule III rescheduling eliminates 280E tax burden and enables traditional banking.
  • Maryland recreational sales exceed $250M with vapes at 35% volume, matching TYSON 2.0 rollout.

What critics are saying

  • Debt facility at 12.75% matures August 2028; refinancing failure triggers covenant breach.
  • Michigan exit signals inability to compete in oversupplied markets; Ohio and New Jersey vulnerable.
  • Federal rescheduling reversible under new administration; DEA raids destroy shareholder value overnight.

What makes TerrAscend unique

  • Vertically integrated operations across five U.S. states with Pennsylvania's largest cultivation footprint.
  • Premium brand portfolio including Cookies, Wana, and TYSON 2.0 celebrity partnerships.
  • TSX-listed structure provides capital access unavailable to U.S.-only cannabis operators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

401(k) Retirement Plan

401(k) Company Match

Employee Assistance Program

Paid Parental Leave

Short & Long Term Disability

Flexible Spending Account

Wellness Program

Employee Discount

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

2%

2 year growth

4%
TerrAscend Corp.
Mar 31st, 2026
Mike Tyson and TerrAscend expand TYSON 2.0 footprint into Pennsylvania and Maryland.

Mike Tyson and TerrAscend expand TYSON 2.0 footprint into Pennsylvania and Maryland. TORONTO, March 31, 2026 (GLOBE NEWSWIRE) - TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced the official launch of TYSON 2.0 products in Pennsylvania and Maryland. This expansion marks the latest milestone in TerrAscend's exclusive partnership with the legendary heavyweight champion's premier cannabis brand. The Knockout Lineup The initial rollout features a curated selection of premium flower and high-potency vapes, available through TerrAscend's Apothecarium dispensaries and third-party wholesale partners: * Pennsylvania: Launching with 3.5g and 28g premium flower jars alongside live resin disposable vapes. * Maryland: Debuting with 3.5g and 14g flower SKUs and distillate vapes, with a wider variety of product formats slated for release throughout 2026. Executive Commentary "Bringing the TYSON 2.0 experience to Pennsylvania and Maryland is something I have been wanting to do for some time," said Mike Tyson, co-founder of the brand. "This brand is a reflection of my personal journey with cannabis, and partnering with TerrAscend allows us to ensure every consumer and patient gets the quality and intensity they deserve." Jason Wild, Executive Chairman of TerrAscend, noted the significance of the expansion: "Mike brings an unmatched level of energy and focus to the industry. Following our success in other markets, we are proud to leverage our cultivation and retail footprint to bring this iconic brand to patients and consumers across PA and MD." Availability TYSON 2.0 products are now in stock at all Apothecarium locations and select partner dispensaries across both states. About TerrAscend TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com. Caution Regarding Cannabis Operations in the United States Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation. While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend's operations and financial performance. Forward-Looking Information This press release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe," "intend", "plan", "forecast", "project", "estimate", "look forward to", "outlook" and other similar expressions, and include, but are not limited to, statements with respect to the Company's expectation of future availability of funds under the uncommitted term loan; and the Company's growth prospects in new and existing markets. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; and the risk factors set out in the Company's most recently filed MD&A, filed with the Canadian securities regulators and available under the Company's profile on SEDAR+ at www.sedarplus.ca and in the section titled "Risk Factors" in the Company's Annual Report for the year ended December 31, 2024 filed with the Securities and Exchange Commission on March 6, 2025. The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether, as a result of new information, future events, or results or otherwise, other than as required by applicable securities laws. Released March 31, 2026

AD HOC NEWS Portal Aktiengesellschaft
Mar 30th, 2026
TerrAscend stock: navigating the evolving cannabis landscape for North American investors.

TerrAscend stock: navigating the evolving cannabis landscape for North American investors. 30.03.2026 - 19:22:34 | ad-hoc-news.de TerrAscend Corp. (ISIN: CA88160R1087) operates as a leading cannabis cultivator and retailer with a strong footprint in key North American markets. Investors eye its growth potential amid regulatory shifts and market consolidation. This analysis explores what drives the stock today and key factors to monitor. TerrAscend Corp. stands as a prominent player in the North American cannabis industry, focusing on cultivation, processing, and retail distribution. Listed under ISIN CA88160R1087 on the Canadian Securities Exchange as TSND, the company targets vertically integrated operations to capture value across the supply chain. For North American investors, TerrAscend represents exposure to the burgeoning legal cannabis market, where evolving regulations and consumer trends shape long-term opportunities. As of: 30.03.2026 By Elena Voss, Senior Financial Editor at NorthStar Market Insights: TerrAscend embodies the resilience of cannabis operators adapting to regulatory maturation in North America. Company overview and business model. Official source All current information on TerrAscend directly from the company's official website. TerrAscend Corp. maintains a vertically integrated business model that spans cultivation, manufacturing, distribution, and retail. This structure allows the company to control quality from seed to sale, a critical advantage in a fragmented industry. Operations center on high-quality flower production and branded products like cookies and concentrates, appealing to recreational and medical consumers alike. The company's portfolio includes state-of-the-art cultivation facilities designed for efficiency and scalability. By focusing on premium genetics and sustainable practices, TerrAscend differentiates itself from commodity producers. Retail banners such as Apothecarium provide direct-to-consumer channels, enhancing brand loyalty and margins. Geographically, TerrAscend holds licenses in multiple U.S. states including New Jersey, Pennsylvania, and California, alongside Canadian operations. This multi-jurisdictional presence mitigates regional risks while positioning the company for national expansion as barriers lower. Investors value this footprint for its potential to capitalize on population density and market maturity. Market position and competitive landscape. Sentiment and reactions In the competitive cannabis sector, TerrAscend competes with multi-state operators (MSOs) like Curaleaf and Green Thumb Industries. Its edge lies in operational efficiency and a focus on East Coast markets, where adult-use legalization drives demand. The company's wholesale distribution strengthens ties with third-party retailers, expanding reach without heavy capital outlay. Market share gains depend on execution in high-growth states. Pennsylvania and New Jersey represent significant opportunities due to large populations and recent regulatory openings. TerrAscend's ability to secure additional licenses or partnerships will define its trajectory against larger peers. Branding plays a pivotal role, with in-house lines gaining traction among discerning consumers. As the industry shifts from price wars to premiumization, TerrAscend's product innovation supports sustained revenue growth. North American investors monitor these dynamics for signs of margin expansion. Sector drivers and regulatory environment. The cannabis sector benefits from ongoing legalization trends across North America. In the U.S., over 24 states have recreational markets, with more under consideration. Canada, post-2018 legalization, sees maturing recreational sales alongside medical stability. TerrAscend navigates a complex regulatory landscape, including state-specific compliance and federal restrictions. Potential U.S. rescheduling of cannabis to Schedule III could unlock banking access and tax relief, benefiting operators like TerrAscend. Investors watch federal progress closely for industry-wide catalysts. Supply chain constraints and potency caps influence production strategies. TerrAscend adapts by optimizing yields and diversifying formats like edibles and vapes. Broader economic factors, such as inflation and consumer spending, also impact discretionary purchases like cannabis. Financial strategy and growth catalysts. TerrAscend pursues a disciplined financial strategy emphasizing cash flow generation and debt reduction. Investments in automation enhance cultivation efficiency, lowering costs per gram. Retail expansion through acquisitions or organic growth bolsters recurring revenue. Key catalysts include license approvals and market share capture in new jurisdictions. Vertical integration minimizes intermediary costs, supporting profitability as wholesale prices stabilize. The company's balance sheet strength allows flexibility for opportunistic moves. For growth-oriented investors, TerrAscend offers leverage to sector tailwinds without excessive dilution risks. Management's track record in integrations signals capability to execute amid consolidation waves sweeping the industry. Investor relevance for North americans. Further developments, updates, and context on the stock can be explored quickly through the linked overview pages. North American investors find TerrAscend appealing due to its U.S.-centric operations, offering indirect exposure to domestic legalization without direct state-level investments. Canadian listing provides liquidity and transparency via SEDAR filings. Currency dynamics between CAD and USD add a layer for U.S. holders. The stock aligns with portfolios seeking high-beta growth in emerging markets. Dividend policies remain secondary to reinvestment, suiting long-term holders. ETF inclusions could boost visibility and trading volume. Performance benchmarks against the MOC index highlight relative strength during sector recoveries. Investors assess TerrAscend for its role in diversified cannabis allocations. Risks and open questions. Regulatory delays pose the primary risk, with federal reform timelines uncertain. State-level enforcement variations could disrupt operations. Intense competition pressures pricing power, especially in oversupplied markets. Execution risks in scaling retail and cultivation persist. Economic downturns may curb consumer spending on non-essentials. Investors should watch cash burn rates and debt covenants closely. Open questions include acquisition pipelines and international ambitions. Path to positive free cash flow remains pivotal. Dilution from financings could impact per-share value if markets weaken. Supply disruptions from weather or input costs add volatility. Black market persistence challenges legal sales growth. North American investors prioritize management's navigation of these hurdles. Disclaimer: Not investment advice. Stocks are volatile financial instruments. Trojaner, Phishing, Datenklau: So schützen Android-Experten ihre eigenen Geräte. Gratis-Sicherheitspaket vom 03. April: Jeden Tag werden 560.000 neue Schad-Apps für Android entdeckt - viele tarnen sich als harmlose Downloads. Die IT-Experten von Computerwissen haben ihre bewährtesten Schutzmaßnahmen in einem kostenlosen Paket zusammengestellt: 5 konkrete Anleitungen, die jeder Android-Nutzer in unter 10 Minuten umsetzen kann. Ohne technische Vorkenntnisse. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen - dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren. Für. Immer. Kostenlos. CA88160R1087 | TERRASCEND | boerse | 69031577 | bgmi

AD HOC NEWS Portal Aktiengesellschaft
Mar 29th, 2026
TerrAscend stock: navigating growth opportunities and regulatory challenges in North america's cannabis sector.

TerrAscend stock: navigating growth opportunities and regulatory challenges in North america's cannabis sector. 29.03.2026 - 08:07:18 | ad-hoc-news.de TerrAscend (ISIN: CA88160R1087) operates as a leading cannabis cultivator and retailer with a strong footprint in key U.S. markets. Investors should monitor regulatory shifts and expansion plans for potential upside. This analysis covers business model, competitive dynamics, and what matters now for North American portfolios. TerrAscend stands as a prominent player in the North American cannabis industry, focusing on cultivation, processing, and retail distribution. The company, listed under ISIN CA88160R1087, trades primarily on the Canadian Securities Exchange (CSE) in Canadian dollars (CAD). Its operations span licensed production facilities and retail banners across several U.S. states, positioning it to capture demand in a market projected to grow steadily amid evolving regulations. As of: 29.03.2026 By Elena Marcus, Senior Financial Editor at NorthStar Market Insights: TerrAscend exemplifies the resilience of multi-state cannabis operators adapting to fragmented U.S. legalization trends. Company overview and core business model. Official source All current information on TerrAscend directly from the company's official website. TerrAscend's business model centers on vertically integrated operations, from seed to sale. This approach allows control over quality, costs, and supply chain efficiency in a competitive landscape. The company cultivates high-quality flower and produces branded products like vapes, edibles, and concentrates under banners such as State Flower and Hobo. Retail operations form a key pillar, with stores under the Apothecarium brand in Pennsylvania and New Jersey. These outlets provide direct consumer access, fostering brand loyalty and higher margins compared to wholesale channels. TerrAscend's focus on premium genetics and innovative extraction methods differentiates it from lower-end competitors. In Canada, legacy operations support international expansion ambitions, though U.S. markets drive the majority of revenue potential. The model's scalability hinges on securing additional licenses and optimizing facility utilization rates. Investors value this integration for its potential to weather price compression in mature markets. Market position and competitive landscape. Sentiment and reactions TerrAscend competes with multi-state operators (MSOs) like Curaleaf, Green Thumb Industries, and Trulieve. Its edge lies in concentrated exposure to high-growth states such as Pennsylvania, New Jersey, and Ohio. These markets feature large populations and medical programs transitioning toward adult-use opportunities. Market share in Pennsylvania, TerrAscend's largest footprint, benefits from limited licenses and strong dispensary performance. Competitive pressures include aggressive pricing from larger peers and illicit market encroachment. However, TerrAscend's wholesale partnerships with brands like Gage Cannabis enhance distribution reach. Sector consolidation trends favor operators with clean balance sheets and operational discipline. TerrAscend's ability to execute acquisitions, like the New Jersey expansion, bolsters its position. North American investors track MSO rankings by revenue per store and EBITDA margins to gauge relative strength. Sector drivers and regulatory environment. The cannabis sector's growth depends on regulatory catalysts at federal and state levels. In the U.S., rescheduling discussions could ease banking access and tax burdens under IRC 280E. Progress here would unlock capital for expansion, benefiting vertically integrated players like TerrAscend. State-level adult-use legalization in Ohio and potential moves in Pennsylvania represent near-term tailwinds. Medical market stability provides baseline revenue, while recreational shifts could double addressable markets. Federal reform remains uncertain, but bipartisan support signals long-term viability. Supply dynamics feature oversupply in mature states like Colorado, pressuring prices, contrasted by shortages in newer markets. TerrAscend's cultivation expertise positions it to capitalize on demand upticks. Investors monitor cultivation tax proposals and interstate commerce bills for broader implications. Financial health and growth strategy. TerrAscend pursues disciplined growth through organic expansion and strategic investments. Facility upgrades in Pennsylvania enhance yields and product diversity. Retail optimization, including loyalty programs, drives same-store sales growth. Balance sheet management emphasizes debt reduction and cash flow generation. Free cash flow positivity would signal maturity, enabling dividends or buybacks in the future. Cost controls in a high-interest environment preserve liquidity for opportunities. International ambitions, via partnerships in Europe, diversify revenue streams. U.S.-centric strategy aligns with North American investor priorities, focusing on high-margin markets. Trailing metrics like revenue growth and adjusted EBITDA guide performance assessments. Further developments, updates, and context on the stock can be explored quickly through the linked overview pages. Investor relevance for North American portfolios. For North American investors, TerrAscend offers exposure to cannabis without direct U.S. listing complexities. CSE trading in CAD provides accessibility via most brokers. Portfolio allocation to emerging sectors like cannabis hedges traditional assets amid inflation and rate shifts. Dividend potential remains distant, but capital appreciation ties to market milestones. ESG considerations include sustainable cultivation practices, appealing to impact-focused funds. Correlation with broader biotech and consumer staples indices aids diversification. Tax implications for U.S. persons involve PFIC rules, warranting advisor consultation. Long-term holders benefit from sector compounding as legalization normalizes. Current valuations, relative to peers, factor into buy/hold decisions. Risks and open questions. Regulatory delays pose the primary risk, stalling revenue ramps. Competitive intensification could erode margins if pricing wars escalate. Operational risks encompass crop failures, compliance breaches, and supply chain disruptions. Macro factors like interest rates impact financing costs for capital-intensive growth. Illicit competition persists, undermining legal market share gains. Debt levels require vigilant monitoring amid refinancing windows. Open questions center on federal reform timelines and state ballot outcomes. Execution risks in expansions test management's track record. Investors watch quarterly updates for guidance on path to profitability. Disclaimer: Not investment advice. Stocks are volatile financial instruments. Windows 10 Support endet - Ihr PC ist "zu alt" für Windows 11? Die Lösung vom 03. April: Millionen Nutzer stehen vor dem Problem: Windows 10 läuft aus, aber Windows 11 verweigert die Installation. Die gute Nachricht: Es gibt einen offiziell geduldeten Workaround. Das Gratis-Paket erklärt jeden Schritt - auch für Computer-Einsteiger verständlich. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen - dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren. Für. Immer. Kostenlos. CA88160R1087 | TERRASCEND | boerse | 69019244 | bgmi

Stockwatch
Jul 9th, 2025
TerrAscend Secures $79M Debt Financing

TerrAscend completed a $79 million non-dilutive debt financing, using $68 million to retire existing debt and allocating the rest for growth initiatives. An additional $35 million facility is available for future M&A. The loan, led by FocusGrowth Asset Management, has a 12.75% interest rate and matures in August 2028. No prepayment penalties or warrants were issued. The transaction includes insider participation by Jason Wild, exempt from certain regulatory requirements.

GlobeNewswire
Jul 9th, 2025
TerrAscend Completes $79 Million Non-Dilutive Debt Financing

Proceeds used to retire $68 million of existing debt with the remainder designated for future growth initiatives Additional facility of up to $35 million...

INACTIVE